physiciansweekly.com
Intestinal Ultrasound for Prognosis in Early Crohn's Disease - Physician's Weekly
This study suggests intestinal ultrasound findings early after diagnosis — especially achieving “transmural remission” within 3 months — may predict better 1-year outcomes (sustained steroid-free remission and less need for treatment escalation) and may help identify patients at higher surgical risk.
Adults with newly diagnosed Crohn’s disease, clinicians who manage IBD (gastroenterologists, IBD nurses, radiologists/sonographers), and researchers studying imaging biomarkers or treatment stratification.
What To Know
This article summarizes a prospective, population-based cohort study assessing intestinal ultrasound (IUS) findings in adults newly diagnosed with Crohn’s disease and their association with outcomes during the first year.
Key reported findings: about 38% of patients had transmural remission by 3 months and 41% by 12 months; early transmural remission at 3 months was linked with sustained steroid-free clinical remission and lower rates of treatment escalation through 12 months. Higher baseline BMI was associated with lower likelihood of long-term transmural remission.
The IBUS-SAS score in the terminal ileum at diagnosis predicted ileocecal resection risk within the first year.
This is a cohort study summarized from Clinical Gastroenterology and Hepatology; it reports associations over the first year but does not itself establish treatment recommendations. IUS scoring systems (like IBUS-SAS) and thresholds may need further validation before routine use to guide individual treatment changes.
The original journal article may have detailed methods and limitations worth reviewing.
